40 results
Keyword Docetaxel Remove keyword
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Medicine type
Additional monitoring Remove Additional monitoring filter
Generic Remove Generic filter
Orphan medicine Remove Orphan medicine filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Docetaxel Mylan
Date of authorisation: 31/01/2012,
, Revision: 6, Withdrawn, Last updated: 12/03/2015
Rev. 1 Public statement Docetaxel Mylan Cessation of validity … marketing authorisation of Docetaxel Mylan docetaxel) ceased to be valid in the … S.A.S., had not marketed Docetaxel Mylan in the EU since its … -
List item
Human medicine European public assessment report (EPAR): Docetaxel Teva
Date of authorisation: 26/01/2010,, Revision: 17, Authorised, Last updated: 05/08/2019
summary for the public Docetaxel Teva docetaxel This is a summary of the … assessment report (EPAR) for Docetaxel Teva. It explains how the … the conditions of use for Docetaxel Teva. What is … -
List item
Human medicine European public assessment report (EPAR): Docetaxel Accord
Date of authorisation: 22/05/2012,, Revision: 12, Authorised, Last updated: 21/06/2019
summary for the public Docetaxel Accord docetaxel This is a summary of the … assessment report (EPAR) for Docetaxel Accord. It explains how … the conditions of use for Docetaxel Accord. What is … -
List item
Human medicine European public assessment report (EPAR): Docetaxel Kabi
Date of authorisation: 22/05/2012,, Revision: 12, Authorised, Last updated: 14/06/2019
summary for the public Docetaxel Kabi docetaxel This is a summary of the … assessment report (EPAR) for Docetaxel Kabi. It explains how the … the conditions of use for Docetaxel Kabi. What is … -
List item
Human medicine European public assessment report (EPAR): Docetaxel Teva Pharma
Date of authorisation: 21/01/2011,, Revision: 6, Withdrawn, Last updated: 21/01/2014
Public statement on Docetaxel Teva Pharma 7 Westferry … Public statement on Docetaxel Teva Pharma Cessation of … marketing authorisation for Docetaxel Teva Pharma … -
List item
Human medicine European public assessment report (EPAR): Taxespira (previously Docetaxel Hospira UK Limited )
Date of authorisation: 28/08/2015,, Revision: 8, Withdrawn, Last updated: 15/10/2019
Taxespira (previously Docetaxel Hospira UK Limited … Taxespira (previously Docetaxel Hospira UK Limited ) Stomach … Taxespira (previously Docetaxel Hospira UK Limited docetaxel docetaxel trihydrate … -
List item
Human medicine European public assessment report (EPAR): Docefrez
Date of authorisation: 10/05/2010,, Revision: 1, Withdrawn, Last updated: 14/06/2012
Docefrez, INN-docetaxel 7 Westferry Circus … statement on Docefrez (Docetaxel) Withdrawal of the marketing … medicinal product Docefrez (docetaxel), which had been approved … -
List item
Human medicine European public assessment report (EPAR): Ogivri
Date of authorisation: 12/12/2018,
, 
, Revision: 2, Authorised, Last updated: 05/08/2019
medicines: with paclitaxel or docetaxel, or with another type of medicine … -
List item
Human medicine European public assessment report (EPAR): Tecentriq
Date of authorisation: 20/09/2017,, Revision: 6, Authorised, Last updated: 23/10/2019
Tecentriq is more effective than docetaxel (another cancer medicine … average while those given docetaxel lived for 10 months. In a … 10 months for patients on docetaxel. In another main study of … -
List item
Human medicine European public assessment report (EPAR): Kanjinti (updated)
Date of authorisation: 16/05/2018,, , Revision: 6, Authorised, Last updated: 29/11/2019
medicines: with paclitaxel or docetaxel, or with another class of … medicines: with paclitaxel or docetaxel, or with another class of … -
List item
Human medicine European public assessment report (EPAR): Opdivo
Date of authorisation: 19/06/2015,, Revision: 28, Authorised, Last updated: 28/10/2019
compared with 9.4 months with docetaxel. For squamous NSCLC, a study … months in patients given docetaxel. Supportive information was … -
List item
Human medicine European public assessment report (EPAR): Ontruzant
Date of authorisation: 15/11/2017,, , Revision: 4, Authorised, Last updated: 07/10/2019
medicines: with paclitaxel or docetaxel, or with another class of … medicines: with paclitaxel or docetaxel, or with another class of … -
List item
Human medicine European public assessment report (EPAR): Trazimera
Date of authorisation: 26/07/2018,, , Revision: 3, Authorised, Last updated: 07/10/2019
medicines: with paclitaxel or docetaxel, or with another class of … medicines: with paclitaxel or docetaxel, or with another class of … -
List item
Human medicine European public assessment report (EPAR): Herzuma
Date of authorisation: 08/02/2018,, , Revision: 6, Authorised, Last updated: 14/08/2019
medicines: with paclitaxel or docetaxel, or with another class of … medicines: with paclitaxel or docetaxel, or with another class of … -
List item
Human medicine European public assessment report (EPAR): Capecitabine Accord
Date of authorisation: 20/04/2012,, Revision: 11, Authorised, Last updated: 13/11/2019
Capecitabine Accord is used with docetaxel (another anticancer medicine … Capecitabine Accord is used with docetaxel (another anticancer medicine … -
List item
Human medicine European public assessment report (EPAR): Ecansya (previously Capecitabine Krka)
Date of authorisation: 20/04/2012,, Revision: 11, Authorised, Last updated: 28/10/2019
body). Ecansya is used with docetaxel (another anticancer medicine … body). Ecansya is used with docetaxel (another anticancer medicine … -
List item
Human medicine European public assessment report (EPAR): Capecitabine Teva
Date of authorisation: 20/04/2012,, Revision: 11, Authorised, Last updated: 14/10/2019
Capecitabine Teva is used with docetaxel (another anticancer medicine … Capecitabine Teva is used with docetaxel (another anticancer medicine … -
List item
Human medicine European public assessment report (EPAR): Capecitabine SUN
Date of authorisation: 21/06/2013,, Revision: 3, Withdrawn, Last updated: 22/12/2016
regimen. - in combination with docetaxel for the treatment of patients … Capecitabine in combination with docetaxel is indicated for the treatment … -
List item
Human medicine European public assessment report (EPAR): Capecitabine Medac (updated)
Date of authorisation: 19/11/2012,, Revision: 9, Authorised, Last updated: 26/11/2019
Capecitabine Medac is used with docetaxel (another anticancer medicine … -
List item
Human medicine European public assessment report (EPAR): Keytruda (updated)
Date of authorisation: 17/07/2015,, Revision: 24, Authorised, Last updated: 11/12/2019
another cancer medicine called docetaxel (around 8 months) and the … -
List item
Human medicine European public assessment report (EPAR): Onivyde pegylated liposomal (previously known as Onivyde) (updated)
Date of authorisation: 14/10/2016,
, Revision: 4, Authorised, Last updated: 18/11/2019
-
List item
Human medicine European public assessment report (EPAR): Zykadia
Date of authorisation: 06/05/2015,, Revision: 12, Authorised, Last updated: 26/08/2019
-
List item
Human medicine European public assessment report (EPAR): Sylvant
Date of authorisation: 22/05/2014,
, , Revision: 10, Authorised, Last updated: 08/10/2019
-
List item
Human medicine European public assessment report (EPAR): Akynzeo
Date of authorisation: 27/05/2015,, Revision: 5, Authorised, Last updated: 10/07/2019
-
List item
Human medicine European public assessment report (EPAR): Imatinib Actavis
Date of authorisation: 17/04/2013,, Revision: 12, Authorised, Last updated: 08/10/2019